Fierce Pharma Feature: Small molecule biomarkers in precision medicine

This contributed piece to Fierce Pharma discusses small molecule biomarkers & how next-gen mass spectrometry is enabling their discovery on an entirely new scale.

Cancers, Free Full-Text

CPHI: ESG Risks in Pharma and Biotech – How to Manage your Exposure (webinar)

Frontiers A global analysis of the value of precision medicine in oncology – The case of non-small cell lung cancer

Fierce Pharma Feature: Small molecule biomarkers in precision medicine

2023's Fiercest Women in Life Sciences

Cancers, Free Full-Text

IJMS, Free Full-Text

Overview Archives - Sapient, Discovery Metabolomics Lab, Small Molecule Biomarkers - Sapient

Biomedicines, Free Full-Text

IJMS, Free Full-Text

Automated next-generation profiling of genomic alterations in human cancers

BDCC, Free Full-Text